首页
>
期刊首页
>
癌症生物学与医学(英文版)
>
2026年9期
>
A foundation model-enhanced CT radiomics signature for the noninvasive assessment of tertiary lymphoid structures and prediction of therapy benefit in gastric cancer
A foundation model-enhanced CT radiomics signature for the noninvasive assessment of tertiary lymphoid structures and prediction of therapy benefit in gastric cancer
摘要
Gastric cancer is a highly heterogeneous tumor type whose treatment responses substantially vary across patients.In recent years,biomarkers have shown promise in guiding individualized treatment regimens for gastric cancer,par-ticularly for targeted therapy and immunotherapy1.Existing biomarkers,including CD8+T-cell infiltration,PD-L1 expres-sion,microsatellite instability,and tumor mutational burden,remain insufficient to reliably stratify patients for chemother-apy or immunotherapy benefit1-3.Therefore,robust,clinically applicable,noninvasive biomarkers are urgently needed to guide perioperative treatment selection.
年,卷(期):
2026, 23(9)
机标分类号:
TP301.6
O213.2
F713.36
在线出版日期:
2026年10月13日